Cargando…
COVID-19 with rheumatic diseases: a report of 5 cases
The coronavirus disease 2019 (COVID-19), the result of an infection with the new virus, SARS-CoV-2, is rapidly spreading worldwide. It is largely unknown whether the occurrence of COVID-19 in patients with rheumatic immune diseases has some specific manifestations, or makes them more prone to rapidl...
Autores principales: | Cheng, Chuanfang, Li, Chuanjing, Zhao, Tao, Yue, Jing, Yang, Fang, Yan, Yimin, Liu, Xiaoan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220846/ https://www.ncbi.nlm.nih.gov/pubmed/32406001 http://dx.doi.org/10.1007/s10067-020-05160-x |
Ejemplares similares
-
Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients
por: Pelechas, Eleftherios, et al.
Publicado: (2022) -
Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy—a report of long-term follow-up of serial cases and literature review
por: Xuan, Dandan, et al.
Publicado: (2013) -
Post-COVID-19 arthritis: a case report and literature review
por: Gasparotto, M., et al.
Publicado: (2021) -
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review
por: Gonzalez, Daniel, et al.
Publicado: (2022) -
Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report
por: Lemoine, Chantal, et al.
Publicado: (2022)